Clinical Trials
6 trialsNCT05366881 2026-01-20
CAMPERR
Adela, Inc
Recruiting
NCT04028479 2024-12-18
ROOT
Taproot Health
Completed
NCT05227898 2022-10-25
RESTORE
Blue Note Therapeutics
Phase NA Unknown
NCT02012231 2020-10-19
Phase I/IIa Study to Evaluate the Safety, PK, PD, and Preliminary Efficacy of PLX8394 in Patients With Advanced Cancers.
Fore Biotherapeutics
Phase 1 Terminated
NCT02223052 2020-05-12
Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies
Celgene
Phase 1 Completed
NCT01831726 2017-03-20
SIGNATURE
Novartis
Phase 2 Completed